Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
As public criticism of vaccines subsides, RFK Jr. continues to investigate safety behind the scenes: NYT
By healthadmin
The Secretary of Health and Human Services is said to be campaigning behind the scenes…
Alkermes’ Lumryz hits Phase 3 mark in another sleep disorder, momentum accelerates with $2.4 billion Avadel acquisition
By healthadmin
Marking a quick clinical win with its $2.37 billion acquisition of Avadel, Alkermes reported on…
Pfizer and Alvinas receive $85 million upfront in Rigel license agreement for new breast cancer drug Vepanu
By healthadmin
Pfizer and Alvinas have found a buyer for their newly approved breast cancer drug Vepanu,…
Since Roche launched Babismo, a long-acting eye disease treatment, in 2022, Bayer and Regeneron have…
European Union advances plan to strengthen manufacturing autonomy and avoid drug shortages
By healthadmin
With positive momentum building on plans for the second half of 2025, European Union legislators…
Bicara Therapeutics prepares to accelerate cancer drug approvals next year, with the biotechnology company appointing…
CSL lowered its revenue forecast for the fiscal year to $15.2 billion from $15.8 billion,…
Targeted protein degradation is changing the way drug discovery teams think about disease biology. For…
Partner Bispecific Bizengri agrees to FDA National Priority Approval in rare bile duct cancer
By healthadmin
With the program’s seventh approval, FDA is demonstrating how quickly it can review drugs that…
Daiichi Sankyo aims to be among the world’s top five oncology patients by 2035, driving $1.3 billion in efficiency gains in new five-year plan
By healthadmin
Daiichi Sankyo aims to transform its antibody-drug conjugate (ADC) leadership into a leading position in…